S. Prusiner and . Prions, Nobel Lecture: Prions, Proceedings of the National Academy of Sciences, vol.389, issue.6650, pp.13363-13383, 1998.
DOI : 10.1038/39097

M. Scott, R. Will, J. Ironside, H. Nguyen, P. Tremblay et al., Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans, Proceedings of the National Academy of Sciences, vol.278, issue.5336, pp.15137-15142, 1999.
DOI : 10.1126/science.278.5336.245

R. Will, J. Ironside, M. Zeidler, S. Cousens, K. Estibeiro et al., A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, pp.921-925, 1996.

G. Hsich, K. Kenney, C. Gibbs, K. Lee, and M. Harrington, The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies, New England Journal of Medicine, vol.335, issue.13, pp.924-930, 1996.
DOI : 10.1056/NEJM199609263351303

I. Zerr, M. Pocchiari, S. Collins, J. Brandel, P. Cuesta et al., Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease, Neurology, vol.55, issue.6, pp.811-815, 2000.
DOI : 10.1212/WNL.55.6.811

I. Zerr, A. Giese, O. Windl, K. S. Schulz-schaeffer, W. Riedemann et al., Phenotypic variability in fatal familial insomnia (D178N-129M) genotype, Neurology, vol.51, issue.5, pp.1398-1405, 1998.
DOI : 10.1212/WNL.51.5.1398

A. Ladogana, M. Puopolo, E. Croes, H. Budka, C. Jarius et al., Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada, Zerr I: Mortality from Creutzfeldt- Jakob disease and related disorders in Europe, Australia, and Canada, pp.1586-1591, 2005.
DOI : 10.1212/01.WNL.0000160117.56690.B2

M. Pocchiari, M. Puopolo, E. Croes, H. Budka, E. Gelpi et al., Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies, Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies, pp.2348-2359, 2004.
DOI : 10.1093/brain/awh249

J. Brandel, M. Preece, P. Brown, E. Croes, J. Laplanche et al., Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet, pp.128-130, 2003.

I. Zerr, H. Kretzschmar, J. Pedro-cuesta, M. Calero, M. Glatzel et al., Genetic prion disease: the EUROCJD experience, Hum Genet, vol.118, pp.166-174, 2005.

M. Glatzel, C. Rogivue, A. Ghani, J. Streffer, L. Amsler et al., Incidence of Creutzfeldt-Jakob disease in Switzerland, The Lancet, vol.360, issue.9327, pp.139-141, 2002.
DOI : 10.1016/S0140-6736(02)09384-4

C. Llewelyn, P. Hewitt, R. Knight, K. Amar, S. Cousens et al., Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion, The Lancet, vol.363, issue.9407, pp.147-421, 2004.
DOI : 10.1016/S0140-6736(04)15486-X

E. Asante, J. Linehan, M. Desbruslais, A. Wood, J. Welch et al., BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein, The EMBO Journal, vol.21, issue.23, pp.6358-6366, 2002.
DOI : 10.1093/emboj/cdf653

H. Budka, A. Aguzzi, P. Brown, J. Brucher, O. Bugiani et al., Neuropathological Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases), Brain Pathology, vol.12, issue.4, pp.575-582, 1995.
DOI : 10.1016/0140-6736(90)91907-R

R. Will, M. Zeidler, G. Stewart, M. Macleod, J. Ironside et al., Diagnosis of new variant Creutzfeldt-Jakob disease, Annals of Neurology, vol.15, issue.5, pp.575-582, 2000.
DOI : 10.1002/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W

B. Steinhoff, S. Racker, G. Herrendorf, S. Poser, S. Grosche et al., Accuracy and Reliability of Periodic Sharp Wave Complexes in Creutzfeldt-Jakob Disease, Archives of Neurology, vol.53, issue.2, pp.162-166, 1996.
DOI : 10.1001/archneur.1996.00550020074017

D. Collie, R. Sellar, M. Zeidler, A. Colchester, R. Knight et al., MRI of Creutzfeldt???Jakob Disease: Imaging Features and Recommended MRI Protocol, Clinical Radiology, vol.56, issue.9, pp.726-739, 2001.
DOI : 10.1053/crad.2001.0771

C. Radbauer, J. Hainfellner, K. Jellinger, P. Pilz, H. Maier et al., Epidemiologie der übertragbaren spongiformen Enzephalopathien (Prion-Krankheiten)in Österreich, Wien Med Wochenschr, vol.148, pp.101-106, 1998.

C. Arpino, S. Conti, M. Masocco, V. Toccaceli, A. Ladogana et al., Creutzfeldt-Jakob Disease Mortality in Italy, 1982???1996, Neuroepidemiology, vol.18, issue.2, pp.92-100, 1982.
DOI : 10.1159/000069412

J. Brandel, N. Delasnerie-lauprêtre, J. Laplanche, J. Hauw, and A. Alperovitch, Diagnosis of Creutzfeldt-Jakob disease: Effect of clinical criteria on incidence estimates, Neurology, vol.54, issue.5, pp.1095-1099, 2000.
DOI : 10.1212/WNL.54.5.1095

A. Saiz, C. Nos, J. Yagüe, A. Domínguez, F. Graus et al., The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia, Journal of Neurology, vol.248, issue.7, pp.592-594, 2001.
DOI : 10.1007/s004150170137

P. Parchi, A. Giese, S. Capellari, P. Brown, W. Schulz-schaeffer et al., Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects, Annals of Neurology, vol.19, issue.2, pp.224-233, 1999.
DOI : 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W

G. Kovács, M. Head, T. Bunn, L. László, R. Will et al., Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease, Neuropathology and Applied Neurobiology, vol.47, issue.5, pp.463-472, 2000.
DOI : 10.1007/s004390050204

A. Alpérovitch, I. Zerr, M. Pocchiari, E. Mitrová, P. Cuesta et al., Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease, The Lancet, vol.353, issue.9165, pp.1673-1674, 1999.
DOI : 10.1016/S0140-6736(99)01342-2